Galatea Kallergi

Patra, ESYE23 26504, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications

The HGF/MET Axis in Advanced Prostate Cancer: From Context-Dependent Biology to Biomarker-Driven Therapeutic Strategies.

The HGF/MET Axis in Advanced Prostate Cancer: From Context-Dependent Biology to Biomarker-Driven Therapeutic Strategies.

Journal: Cancers
Published: March 19, 2026

Combinatorial Analysis of CD4+Tregs, CD8+Teffs, and Inflammatory Indices Predict Response to ICI in ES-SCLC Patients.

Combinatorial Analysis of CD4+Tregs, CD8+Teffs, and Inflammatory Indices Predict Response to ICI in ES-SCLC Patients.

Journal: Cancers
Published: December 06, 2025

Repurposing Artesunate to Combat Progression and Metastasis via Targeting Circulating Tumor Cells.

Repurposing Artesunate to Combat Progression and Metastasis via Targeting Circulating Tumor Cells.

Journal: Oncology research
Published: November 04, 2025

Profiling of circulating T-cells with prognostic and predictive value in early and advanced stage PDAC.

Profiling of circulating T-cells with prognostic and predictive value in early and advanced stage PDAC.

Journal: Cancer immunology, immunotherapy : CII
Published: June 17, 2025

Metabolic marker profiling of circulating tumour cells in NSCLC patients treated with osimertinib: focus on MCT1 and MCT4.

Metabolic marker profiling of circulating tumour cells in NSCLC patients treated with osimertinib: focus on MCT1 and MCT4.

Journal: Therapeutic advances in medical oncology
Published: June 16, 2025

Transferrin receptor-based circulating tumor cell enrichment provides a snapshot of the molecular landscape of solid tumors and correlates with clinical outcomes.

Transferrin receptor-based circulating tumor cell enrichment provides a snapshot of the molecular landscape of solid tumors and correlates with clinical outcomes.

Journal: medRxiv : the preprint server for health sciences
Published: July 01, 2024

Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment.

Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment.

Journal: Frontiers in oncology
Published: May 20, 2024

Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients.

Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients.

Journal: Cells
Published: March 20, 2024

STIM1, ORAI1, and KDM2B in circulating tumor cells (CTCs) isolated from prostate cancer patients.

STIM1, ORAI1, and KDM2B in circulating tumor cells (CTCs) isolated from prostate cancer patients.

Journal: Frontiers in cell and developmental biology
Published: March 11, 2024

Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approach.

Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approach.

Journal: Molecular oncology
Published: January 30, 2024

Role of KDM2B epigenetic factor in regulating calcium signaling in prostate cancer cells.

Role of KDM2B epigenetic factor in regulating calcium signaling in prostate cancer cells.

Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: January 29, 2024

ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment.

ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment.

Journal: Biomedicines
Published: December 06, 2023
Showing 1-12 of 53

Last Updated: 09/26/2026